Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

AXLA

Axcella Health (AXLA)

Axcella Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXLA
DateHeureSourceTitreSymboleSociété
22/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXLAAxcella Health Inc
17/11/202314h47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AXLAAxcella Health Inc
17/11/202314h28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXLAAxcella Health Inc
06/11/202315h22Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AXLAAxcella Health Inc
14/09/202322h30Business WireAxcella Announces Reverse Stock Split Effective September 19, 2023NASDAQ:AXLAAxcella Health Inc
29/08/202314h00Business WireAxcella Granted Patent for Long COVID Fatigue TreatmentNASDAQ:AXLAAxcella Health Inc
18/08/202322h20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AXLAAxcella Health Inc
03/08/202322h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXLAAxcella Health Inc
03/08/202313h30Business WireAxcella Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
29/06/202322h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXLAAxcella Health Inc
04/05/202322h39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AXLAAxcella Health Inc
04/05/202322h30Business WireAxcella Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
17/04/202314h00Business WireAxcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023NASDAQ:AXLAAxcella Health Inc
30/03/202322h14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AXLAAxcella Health Inc
30/03/202314h00Business WireAxcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
03/03/202322h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXLAAxcella Health Inc
15/02/202322h10Business WireAxcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
14/02/202312h26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AXLAAxcella Health Inc
09/02/202322h45Business WireAxcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma ConferenceNASDAQ:AXLAAxcella Health Inc
24/01/202315h20AllPennyStocks.comStrong Premarket Bid For This Micro CapNASDAQ:AXLAAxcella Health Inc
23/01/202323h03Dow Jones NewsAxcella Health Shares Surge 53% on U.K. Regulator Guidance on AXA1125 for Long Covid FatigueNASDAQ:AXLAAxcella Health Inc
23/01/202322h15Business WireAxcella Announces Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
15/12/202202h01Business WireAxcella Announces Program Reprioritization and Corporate RestructuringNASDAQ:AXLAAxcella Health Inc
04/11/202206h06TipRanksSVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202213h05TipRanksNoble Financial Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202211h50TipRanksAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
18/10/202214h13TipRanksThis Insider Bought Axcella Health (NASDAQ:AXLA) Stock Worth $6MNASDAQ:AXLAAxcella Health Inc
17/10/202222h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXLAAxcella Health Inc
17/10/202222h32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXLAAxcella Health Inc
13/10/202213h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXLAAxcella Health Inc
 Showing the most relevant articles for your search:NASDAQ:AXLA